Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Administration JMKX003142 in Chinese Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Single, and Multiple Ascending Dose Phase I Clinical Trial
Drug Design, Development and Therapy · 2026-03 · Volume 20 · 1-19
DOI: 10.2147/dddt.s583445 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-03. Verfasst von Cheng Cui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, People's Republic of China. Hauptthemen laut MEDLINE: Receptors, Vasopressin, Antidiuretic Hormone Receptor Antagonists. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
- Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
- Beijing Key Laboratory of Clinical Evaluation of Cardiovascular-Kidney-Metabolic and Immuno-Inflammatory Innovative Drugs and Medical Devices, Peking University Third Hospital, Beijing, 100191, People's Republic of Chin…
- Clinical Development Center, Shanghai Jeyou Pharmaceutical Co.,Ltd., Shanghai, 200120, People's Republic of China.
ORCID-Profile: Dongyang Liu
Zitieren
APA
Cui, C., Zhu, J., Liu, Z., Liu, J., Huang, X., Liu, Y., Hu, J., Zhang, L., Zhang, X., Sha, Y., Liu, D., & Li, H. (2026). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Administration JMKX003142 in Chinese Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Single, and Multiple Ascending Dose Phase I Clinical Trial. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s583445
Vancouver
Cui C, Zhu J, Liu Z, Liu J, Huang X, Liu Y, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Administration JMKX003142 in Chinese Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Single, and Multiple Ascending Dose Phase I Clinical Trial. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s583445
BibTeX
@article{Cui2026,
author = {Cui, Cheng and Zhu, Jixiang and Liu, Zhiping and Liu, Jingyao and Huang, Xiaomin and Liu, Yi and Hu, Jingqiu and Zhang, Lingli and Zhang, Xue and Sha, Yila and Liu, Dongyang and Li, Haiyan},
title = {Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Administration JMKX003142 in Chinese Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Single, and Multiple Ascending Dose Phase I Clinical Trial},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--19},
doi = {10.2147/dddt.s583445}
}
EUVIMED